These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 17873605

  • 1. Primary liver cancers with nonalcoholic steatohepatitis.
    Hashizume H, Sato K, Takagi H, Hirokawa T, Kojima A, Sohara N, Kakizaki S, Mochida Y, Shimura T, Sunose Y, Ohwada S, Mori M.
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):827-34. PubMed ID: 17873605
    [Abstract] [Full Text] [Related]

  • 2. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
    Reddy SK, Steel JL, Chen HW, DeMateo DJ, Cardinal J, Behari J, Humar A, Marsh JW, Geller DA, Tsung A.
    Hepatology; 2012 Jun; 55(6):1809-19. PubMed ID: 22183968
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I, Tannapfel A.
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [Abstract] [Full Text] [Related]

  • 5. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
    Portolani N, Baiocchi GL, Coniglio A, Piardi T, Grazioli L, Benetti A, Ferrari Bravo A, Giulini SM.
    Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
    [Abstract] [Full Text] [Related]

  • 6. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL.
    Ned Tijdschr Geneeskd; 2005 Feb 05; 149(6):289-94. PubMed ID: 15730035
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Malik SM, Gupte PA, de Vera ME, Ahmad J.
    Clin Gastroenterol Hepatol; 2009 Jul 05; 7(7):800-6. PubMed ID: 19281869
    [Abstract] [Full Text] [Related]

  • 10. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H, Shiratori K, Yamamoto M, Takasaki K, Nakano M.
    J Gastroenterol Hepatol; 2006 May 05; 21(5):869-73. PubMed ID: 16704538
    [Abstract] [Full Text] [Related]

  • 11. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
    Cuadrado A, Orive A, García-Suárez C, Domínguez A, Fernández-Escalante JC, Crespo J, Pons-Romero F.
    Obes Surg; 2005 Mar 05; 15(3):442-6. PubMed ID: 15826485
    [Abstract] [Full Text] [Related]

  • 12. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
    Yoshioka Y, Hashimoto E, Yatsuji S, Kaneda H, Taniai M, Tokushige K, Shiratori K.
    J Gastroenterol; 2004 Dec 05; 39(12):1215-8. PubMed ID: 15622489
    [Abstract] [Full Text] [Related]

  • 13. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
    Yamamoto M, Ariizumi S, Otsubo T, Katsuragawa H, Katagiri S, Nakano M, Takasaki K.
    J Surg Oncol; 2004 Aug 01; 87(2):80-3; discussion 83-4. PubMed ID: 15282700
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Zuo HQ, Yan LN, Zeng Y, Yang JY, Luo HZ, Liu JW, Zhou LX.
    Hepatobiliary Pancreat Dis Int; 2007 Apr 01; 6(2):161-5. PubMed ID: 17374575
    [Abstract] [Full Text] [Related]

  • 15. The epidemiology of nonalcoholic fatty liver disease in adults.
    Clark JM.
    J Clin Gastroenterol; 2006 Mar 01; 40 Suppl 1():S5-10. PubMed ID: 16540768
    [Abstract] [Full Text] [Related]

  • 16. Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma.
    Takamatsu S, Noguchi N, Kudoh A, Nakamura N, Kawamura T, Teramoto K, Igari T, Arii S.
    Hepatogastroenterology; 2008 Mar 01; 55(82-83):609-14. PubMed ID: 18613418
    [Abstract] [Full Text] [Related]

  • 17. Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder.
    Ikeda H, Suzuki M, Takahashi H, Kobayashi M, Okuse N, Moriya H, Koike J, Maeyama S, Yotsuyanagi H, Itoh F.
    Pathol Int; 2006 Jan 01; 56(1):40-5. PubMed ID: 16398679
    [Abstract] [Full Text] [Related]

  • 18. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
    Neeff H, Makowiec F, Harder J, Gumpp V, Klock A, Thimme R, Drognitz O, Hopt UT.
    Zentralbl Chir; 2009 Apr 01; 134(2):127-35. PubMed ID: 19382043
    [Abstract] [Full Text] [Related]

  • 19. [A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy].
    Hayashi H, Beppu T, Ishiko T, Mizumoto T, Masuda T, Okabe K, Baba Y, Okabe H, Takamori H, Kanemitsu K, Hiroto M, Baba H.
    Gan To Kagaku Ryoho; 2006 Nov 01; 33(12):1941-3. PubMed ID: 17212153
    [Abstract] [Full Text] [Related]

  • 20. [Three cases of hepatocellular carcinoma, over 3 cm in diameter, with liver cirrhosis treated with combination of radiofrequency ablation and continuous hepatic arterial infusion chemotherapy].
    Hirashita T, Nakashima K, Sakai M, Sakai I.
    Gan To Kagaku Ryoho; 2007 Jul 01; 34(7):1123-6. PubMed ID: 17637554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.